Science News: ESC Congress 2013

Updated:Aug 25,2014
ESC 2013 Banner

SCIENCE NEWS coverage includes a daily summary of the science presented at the meeting, summary slides for selected late-breaking clinical trials presented in Hot Line sessions, and links to other AHA science related to the Hot Line topics for each day.

Post-conference Highlights feature video interviews with expert volunteers from the American Heart Association who will discuss the science presented during the meeting, its potential impact on clinical practice, and its possible future benefit to patients.

Hot Line I: Late Breaking Trials on Thrombosis
Sunday, Sept. 1
Click on the hyperlinks below to access the full SCIENCE NEWS coverage for that trial including summary slides and related science and statistics.
Hokusai VTE: Edoxaban for the Long-term Treatment of Venous Thromboembolism
Elliot Antman video still ESC 13 200x122Thrombosis Science—Elliot Antman, MD


Hot Line II: Late Breaking Trials on Interventions and Devices
Sunday, Sept. 1
Click on the hyperlinks below to access the full SCIENCE NEWS coverage for that trial including summary slides and related science and statistics.
PRAMI: Preventive Angioplasty in Myocardial Infarction
ACCOAST: A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction
DECAAF: Delayed Enhancement-MRI Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation
LINC: A Comparison of Conventional Adult Out-of-hospital Cardiopulmonary Resuscitation Against a Concept With Mechanical Chest Compressions and Simultaneous Defibrillation
IN-TIME: Influence of Home Monitoring on the Clinical Status of Heart Failure Patients
 Patel Harrington video still ESC 13 200x122Interventional Trials—Manesh Patel, MD, and Bob Harrington, MD


Hot Line III: Late Breaking Trials on Risk Factors and Diabetes
Monday, Sept. 2
Click on the hyperlinks below to access the full SCIENCE NEWS coverage for that trial including summary slides and related science and statistics.
PURE: Prospective Urban Rural Epidemiology—the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries
EXAMINE: EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome
SAVOR-TIMI 53: saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction
COMPARE: COzaar in Marfan Patients Reduces aortic Enlargement—Losartan therapy and aortic dilation rates in adults with Marfan syndrome, 3-year follow-up
Arnett Robinson video still ESC 13 200x122Risk Factors and Diabetes Science—Donna K. Arnett, PhD and Rose Marie Robertson, MD


Hot Line IV: Late Breaking Trials on Heart Failure and Acute Coronary Syndrome
Tuesday, Sept. 3
Click on the hyperlinks below to access the full SCIENCE NEWS coverage for that trial including summary slides and related science and statistics.
BIC-8: Instant early rule-out using cardiac troponin and copeptin in low- to intermediate-risk patients with suspected ACS: A prospective, randomized multicenter study
Clyde Yancy video still ESC 13 200x122Heart Failure Trials—Clyde Yancy, MD
Mariel Jessup video still ESC 13 200x122EchoCRT, BIC-8—Mariell Jessup, MD



ESC photo 1 - outside convention hallBhatt-SAVOR-TIMI-53 photo ESC 13
ESC Congress 2013 is being held at the RAI Congress Centre in Amsterdam, The Netherlands.Dr. Deepak Bhatt discusses findings of the SAVOR-TIMI 53 trial.




Scientific Sessions 2013 Banner 728x90 with dates

Connect with AHA Science News

Follow AHAScience on Twitter (opens in new window)
Like AHA Science News on Facebook (opens in new window)
Noticias Cientificas
Summer 2014

To submit feedback or to subscribe, follow @AHAScience (opens in new window) on Twitter and use #NoticiasCientíficas (opens in new window).
Sessions 13 Global Networking OnMessage 250x250 ad

AHA Science News on YouTube



Subscribe to AHA's Science News Channel (opens in new window) on YouTube for exclusive, late-breaking coverage of over 200 video interviews, panel discussions, welcome messages and more.